Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
McKinsey
Merck
McKesson
Boehringer Ingelheim

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 6,419,920

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,419,920
Title: Hybrid matrix implants and explants
Abstract:A composition having a body of matrix material made up of insoluble collagen fibrils, and disposed therewithin (a) a plurality of vertebrate cells; (b) a plurality of microspheres; and (c) an agent such as a factor that promotes vascularization, a cytokine, a growth factor, or ascorbic acid.
Inventor(s): Mineau-Hanschke; Rochelle (Andover, MA)
Assignee: Trans Karyotic Therapies, Inc. (Cambridge, MA)
Application Number:09/413,715
Patent Claims:see list of patent claims

Details for Patent 6,419,920

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Nps Pharmaceuticals, Inc. NATPARA parathyroid hormone For Injection 125511 2015-01-23 ⤷  Try it Free 2015-10-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Mallinckrodt
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.